Evaluation of response to chemotherapy in patients affected with non-small cell lung cancer by means of three tumour markers elaborated by discriminant analysis

Respiratory Medicine

Volumn 91, Issue 6, 1997, Pages 361-367

  Paone, G ^a   De Angelis, G ^b   Greco, S ^a   Portalone, L ^d   De Marchis, L ^a   Galluccio, G ^b   Taglienti, A ^a   Bisetti, A ^a   Ameglio, F ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^c SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

^d Istituto S Gallicano ^*

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CISPLATIN; CYTOKERATIN 19 FRAGMENT; MITOMYCIN; NEURON SPECIFIC ENOLASE; TISSUE POLYPEPTIDE ANTIGEN; TUMOR MARKER; VINDESINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TUMOR GROWTH; TUMOR VOLUME;

EID: 0031008414     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(97)90063-9     Document Type: Article

References (30)

1. Ginsberg RJ, Kris MG, Armstrong JG. Cancer of the lung. In De Vita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology, 4th edition. Philadelphia: JB Lippincott Co., 1993.
2. Murren JR, Buzaid AC. Chemotherapy and radiation for the treatment of non-small cell lung cancer. Clin Chest Med 1993; 14: 161-171.
3. Ihde DC, Minna JD. Non-small cell lung cancer part II: treatment. Curr Probl Cancer 1991; 15: 109-154.
4. Souquet PJ, Chauvin F, Boissel JP et al. Polychemotherapy in advanced non-small cell lung cancer: a meta-analysis. Lancet 1993; 342: 19-21.
5. Non-small cell lung cancer collaborative group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized trials. Br Med J 1995; 311: 899-909.
6. WHO Handbook of reporting results of cancer treatment. Offset publication 48. Geneva: World Health Organization, 1979.
7. Ferrigno D, Buccheri G. Clinical application of serum markers for lung cancer. Respir Med 1995; 89: 587-597.
8. Buccheri G, Ferrigno D. Prognostic value of tissue polypeptide antigen in lung cancer. Chest 1992; 101: 1287-1292.
9. Cooper EH. Neuron specific enolase. Int J Biol Markers 1994; 4: 205-210.
10. Niliski J, Furman M, Chyczewska E, Chyczewiski L, Rogowski F, Laudanski J. Diagnostic and prognostic value of the new tumour marker CYFRA 21.1 in patients with squamous cell lung cancer. Eur Respir J 1995; 8: 291-294.
11. Buccheri G, Violante B, Sartoris AM, Ferrigno D, Curcio A, Vola F. Clinical value of a multiple biomarker assay in patients with bronchogenic carcinoma. Cancer 1986; 57: 2389-2396.
12. Lombardi C, Tassi GF, Pizzocolo G, Donato F. Clinical significance of a multiple biomarker assay in patients with lung cancer. Chest 1990; 97: 639-644.
13. Buccheri G, Ferrigno D, Vola F. Carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA), and other prognostic indicators in squamous cell lung cancer. Lung Cancer 1993; 10: 21-33.
14. American Joint Committee on Cancer (1988). In Beahrs OH, Henson DE, Hutter RV, Myers MH, eds. Manual for Staging of Cancer. Philadelphia: Lippincott, pp. 115-122.
15. Cooper EH, Splinter TAW, Brown DA, Meurs MF, Peake MD, Pearson SL. Evaluation of a radioimmunoassay for neuron specific enolase in small cell lung cancer. Br J Cancer 1985; 52: 333-338.
16. BMDP Statistical software. Department of Biomathematics, University of California, Los Angeles, University of California Press, 1988.
17. Overall JE, Kleitt JC. Applied multivariate analysis. In: Use of the Canonic Variable for Classification. New York: McGraw Hill Inc, 1978.
18. Thompson EM, Proce AB, Altman DG, Sowter C, Slavin G. Quantitation in inflammatory bowel disease using computerized interactive image analysis. J Clin Pathol 1985; 38: 631-638.
19. Pujol JL, Grenier J, Daurès JP, Daver A, Pujol H, Michel FB. Serum fragment of cytokeratin subunit 19 measured by Cyfra 21-1. Immunoradiometric assay as a marker of lung cancer. Cancer Res 1993; 53: 61-66.
20. Mizushima Y, Tsuji H, Izumi S et al. Clinical evaluation of five tumor markers assay in patients with lung cancer. Anticancer Res 1991; 11: 91-95.
21. Van der Gaast A, Shoenmakers CHH, Kok TC, Blijemberg BG, Cornillie F, Splinter TAW. Evaluation of a new tumour marker in patient with non-small-cell lung cancer. Br J Cancer 1994; 69: 525-528.
22. Buamah PK, Drake SR, Smedley HM, Bodger WAH, Skillen AW. Neuron specific enolase during chemotherapy of small cell lung cancer. J Surg Oncol 1990; 44: 1-4.
23. Paone G, De Angelis G, Munno R et al. Discriminant analysis on small cell lung cancer and non-small-cell lung cancer by means of NSE and CYFRA-21.1. Eur Respir J 1995; 8: 1136-1140.
24. Ameglio F, Abbolito MR, Giannarelli D et al. Detection of Helicobacter pylori carries by discriminant analysis of urea and pH levels in gastric juices. J Clin Pathol 1991; 44: 697-698.
25. Ameglio F, Giannarelli D, Cordiali-Fei P et al. Use of discriminant analysis to assess disease activity in pulmonary tuberculosis with a panel of specific and non-specific serum markers. Am J Clin Pathol 1994; 101: 719-725.
26. Shinozaki T, Chigira M, Kato K. Multivariate analysis of serum tumor markers for diagnosis of skeletal metastases. Cancer 1992; 69: 108-112.
27. Iskandrian AS, Heo J, Lemiek J, Ogilby JD. Identification of high risk patients with left main and three-vessels coronary disease using stepwise discriminant analysis of clinical, exercise and tomografic thallium data. Am Heart J 1993; 125: 221-225.
28. Zandwijk N, van Jassem E, Bonfer JM, Mooij WJ, van Tinteren H. Serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy and survival in non-small-cell lung cancer. Semin Oncol 1992; 19 (Suppl 2): 37-43.
29. Diez M, Torres A, Ortega L et al. Value of serum neuron-specific enolase in non-small-cell lung cancer. Oncology 1993; 50: 127-131.
30. Eagan RT, Flemming TR, Schoonover V. Evaluation of response criteria in advanced lung cancer. Cancer 1979; 44: 1125-1128.